Skip to main content

Seqirus Leadership Team

 The Seqirus Leadership Team has deep expertise in the business of influenza and a shared commitment to public health.

Stephen Marlow

Stephen Marlow

General Manager

Kian Meng Lim

Ken Lim

Senior Vice President, Strategy & Finance

Chris Larkins

Chris Larkins

Senior Vice President, Global Operations

Dr. Jonathan Edelman

Jonathan Edelman

Interim CSL R&D Seqirus Vaccine Innovation Unit (SVIU) Lead

Lorna Meldrum

Lorna Meldrum

Vice President, Commercial Operations, International Markets & Pandemic

David Ross

Dave Ross

Vice President Commercial Operations, North America

Judi Badenoch, interim VP, Human Resources

Judi Badenoch

Interim VP, Human Resources

Gregg Sylvester

Gregg Sylvester

Chief Health Officer

Sharon McHale

Sharon McHale

Vice President, Global Head of Policy & Government Affairs

Karen Netherton

Karen Netherton

Vice President, Quality

Marcus de Alwis

Marcus de Alwis

Vice President, General Counsel

Canadian Leadership

Bertrand Roy

Bertrand Roy, Ph.D.

Country Head, Medical Affairs, Canada

Gillian Stafford

Gill Stafford

Commercial Operations Director, Canada

Our Values

Seqirus shares the CSL Group Values which have guided the company for many decades. Our Values are fundamental to our success — helping us to save lives, protect the health of people, and earn our reputation as a trusted and reliable global leader. They’re at the core of how our employees interact with others, make decisions and solve problems. 
They are:

Patient Focus

Patient Focus

We deliver on our promise to patients.

Research and Innovation from Seqirus

Innovation

We turn innovative thinking into solutions.

Integrity

Integrity

We walk the talk.

Collaboration

Collaboration

We are stronger together.

Superior Performance

Superior Performance

We take pride in our results.

CAN-CRP-22-0009